The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic

Geng, LL; Lam, KSL; Xu, AM

Xu, AM (corresponding author), Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong, Peoples R China.; Xu, AM (corresponding author), Univ Hong Kong, Dept Med, Hong Kong, Peoples R China.; Xu, AM (corresponding author), Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Peoples R China.

NATURE REVIEWS ENDOCRINOLOGY, 2020; 16 (11): 654

Abstract

Fibroblast growth factor 21 (FGF21) confers considerable pharmacological benefits on a cluster of obesity-related metabolic complications when adminis......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索